FARALLON CAPITAL MANAGEMENT LLC 13D and 13G filings for Enanta Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-11 1:08 pm Sale |
2021-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
FARALLON CAPITAL MANAGEMENT LLC | 1,573,829 7.700% |
-201,171 (-11.33%) |
Filing |
| 2021-02-12 6:42 pm Purchase |
2020-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
FARALLON CAPITAL MANAGEMENT LLC | 1,775,000 8.800% |
25,000 (+1.43%) |
Filing |